Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub- retinal pigment epithelium (sub-RPE) or subretinal space.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Choroidal Neovascularization industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Intravenous
Intravitreal
Market Segment by Product Application
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Valeant Pharmaceuticals International Inc.
Gilead Sciences Inc
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Choroidal Neovascularization consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Choroidal Neovascularization market by identifying its various subsegments.
3.Focuses on the key global Choroidal Neovascularization manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Choroidal Neovascularization with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Choroidal Neovascularization submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Choroidal Neovascularization Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Choroidal Neovascularization Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Choroidal Neovascularization Segment by Type
2.1.1 Intravenous
2.1.2 Intravitreal
2.2 Market Analysis by Application
2.2.1 Extreme Myopia
2.2.2 Malignant Myopic Degeneration
2.2.3 Age-Related Developments
2.3 Global Choroidal Neovascularization Market Comparison by Regions (2017-2027)
2.3.1 Global Choroidal Neovascularization Market Size (2017-2027)
2.3.2 North America Choroidal Neovascularization Status and Prospect (2017-2027)
2.3.3 Europe Choroidal Neovascularization Status and Prospect (2017-2027)
2.3.4 China Choroidal Neovascularization Status and Prospect (2017-2027)
2.3.5 Japan Choroidal Neovascularization Status and Prospect (2017-2027)
2.3.6 Southeast Asia Choroidal Neovascularization Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Choroidal Neovascularization Industry Impact
2.5.1 Choroidal Neovascularization Business Impact Assessment - Covid-19
2.5.2 Market Trends and Choroidal Neovascularization Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Choroidal Neovascularization Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Choroidal Neovascularization Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Choroidal Neovascularization Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Choroidal Neovascularization Manufacturer Market Share
3.5 Top 10 Choroidal Neovascularization Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Choroidal Neovascularization Market
3.7 Key Manufacturers Choroidal Neovascularization Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Choroidal Neovascularization Industry Key Manufacturers
4.1 Pfizer Inc.
4.1.1 Compan Detail
4.1.2 Pfizer Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.1.3 Pfizer Inc. 135 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer Inc. News
4.2 F. Hoffmann-La Roche Ltd.
4.2.1 Compan Detail
4.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Introduction, Application and Specification
4.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer Inc. News
4.3 Novartis AG
4.3.1 Compan Detail
4.3.2 Novartis AG Choroidal Neovascularization Product Introduction, Application and Specification
4.3.3 Novartis AG Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novartis AG News
4.4 Regeneron Pharmaceuticals Inc.
4.4.1 Compan Detail
4.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Regeneron Pharmaceuticals Inc. News
4.5 Bayer AG
4.5.1 Compan Detail
4.5.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.5.3 Bayer AG Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Bayer AG News
4.6 QLT Inc.
4.6.1 Compan Detail
4.6.2 QLT Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.6.3 QLT Inc. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 QLT Inc. News
4.7 Sanwa Kagaku Kenkyusho Co. Ltd.
4.7.1 Compan Detail
4.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Introduction, Application and Specification
4.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Promedior Inc.
4.8.1 Compan Detail
4.8.2 Promedior Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.8.3 Promedior Inc. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Promedior Inc. News
4.9 Valeant Pharmaceuticals International Inc.
4.9.1 Compan Detail
4.9.2 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Product Introduction, Application and Specification
4.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Valeant Pharmaceuticals International Inc. News
4.10 Gilead Sciences Inc
4.10.1 Compan Detail
4.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Introduction, Application and Specification
4.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Gilead Sciences Inc News
5 Global Choroidal Neovascularization Market Segment by Big Type
5.1 Global Choroidal Neovascularization Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Choroidal Neovascularization Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Choroidal Neovascularization Revenue and Market Share by Big Type (2017-2022)
5.2 Intravenous Sales Growth Rate and Price
5.2.1 Global Intravenous Sales Growth Rate (2017-2022)
5.2.2 Global Intravenous Price (2017-2022)
5.3 Intravitreal Sales Growth Rate and Price
5.3.1 Global Intravitreal Sales Growth Rate (2017-2022)
5.3.2 Global Intravitreal Price (2017-2022)
6 Global Choroidal Neovascularization Market Segment by Big Application
6.1 Global Choroidal Neovascularization Sales Market Share by Big Application (2017-2022)
6.2 Extreme Myopia Sales Growth Rate (2017-2022)
6.3 Malignant Myopic Degeneration Sales Growth Rate (2017-2022)
6.4 Age-Related Developments Sales Growth Rate (2017-2022)
7 Global Choroidal Neovascularization Forecast
7.1 Global Choroidal Neovascularization Revenue, Sales and Growth Rate (2022-2027)
7.2 Choroidal Neovascularization Market Forecast by Regions (2022-2027)
7.2.1 North America Choroidal Neovascularization Market Forecast (2022-2027)
7.2.2 Europe Choroidal Neovascularization Market Forecast (2022-2027)
7.2.3 China Choroidal Neovascularization Market Forecast (2022-2027)
7.2.4 Japan Choroidal Neovascularization Market Forecast (2022-2027)
7.2.5 Southeast Asia Choroidal Neovascularization Market Forecast (2022-2027)
7.2.6 Other Regions Choroidal Neovascularization Market Forecast (2022-2027)
7.3 Choroidal Neovascularization Market Forecast by Type (2022-2027)
7.3.1 Global Choroidal Neovascularization Sales Forecast by Type (2022-2027)
7.3.2 Global Choroidal Neovascularization Market Share Forecast by Type (2022-2027)
7.4 Choroidal Neovascularization Market Forecast by Application (2022-2027)
7.4.1 Global Choroidal Neovascularization Sales Forecast by Application (2022-2027)
7.4.2 Global Choroidal Neovascularization Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Choroidal Neovascularization Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Choroidal Neovascularization Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Choroidal Neovascularization
Figure Market Concentration Ratio and Market Maturity Analysis of Choroidal Neovascularization
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Choroidal Neovascularization Market Size by Big Type
Figure Global Market Share of Choroidal Neovascularization by Big Type in 2021
Figure Intravenous Picture (2017-2022)
Global Choroidal Neovascularization Market Size by Big Application
Table Global Choroidal Neovascularization Market Size by Application
Figure Global Choroidal Neovascularization Market Share by Big Application in 2021
Figure Extreme Myopia Picture
Figure Malignant Myopic Degeneration Picture
Figure Age-Related Developments Picture
Table Global Choroidal Neovascularization Comparison by Regions (M USD) ?2017-2027?
Figure Global Choroidal Neovascularization Market Size (Million US$) (2017-2027)
Figure North America Choroidal Neovascularization Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Choroidal Neovascularization Revenue (Million US$) Growth Rate (2017-2027)
Figure China Choroidal Neovascularization Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Choroidal Neovascularization Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Choroidal Neovascularization Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Choroidal Neovascularization Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Choroidal Neovascularization Sales by Manufacturer (2017-2022)
Figure Global Choroidal Neovascularization Sales Market Share by Manufacturer in 2021
Table Global Choroidal Neovascularization Revenue by Manufacturer (2017-2022)
Figure Global Choroidal Neovascularization Revenue Market Share by Manufacturer in 2021
Table Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Choroidal Neovascularization Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Choroidal Neovascularization Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Choroidal Neovascularization Market
Table Key Manufacturers Choroidal Neovascularization Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Inc. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Pfizer Inc.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of F. Hoffmann-La Roche Ltd.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Novartis AG
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Regeneron Pharmaceuticals Inc. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Regeneron Pharmaceuticals Inc.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Regeneron Pharmaceuticals Inc. Main Business
Table Regeneron Pharmaceuticals Inc. Recent Development
Table Regeneron Pharmaceuticals Inc. Main Business
Table Regeneron Pharmaceuticals Inc. Recent Development
Table Bayer AG Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Bayer AG
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table QLT Inc. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of QLT Inc.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table QLT Inc. Main Business
Table QLT Inc. Recent Development
Table Sanwa Kagaku Kenkyusho Co. Ltd. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Sanwa Kagaku Kenkyusho Co. Ltd.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanwa Kagaku Kenkyusho Co. Ltd. Main Business
Table Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development
Table Promedior Inc. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Promedior Inc.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Promedior Inc. Main Business
Table Promedior Inc. Recent Development
Table Valeant Pharmaceuticals International Inc. Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Valeant Pharmaceuticals International Inc.
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Valeant Pharmaceuticals International Inc. Main Business
Table Valeant Pharmaceuticals International Inc. Recent Development
Table Gilead Sciences Inc Company Profile
Table Choroidal Neovascularization Product Introduction, Application and Specification of Gilead Sciences Inc
Table Choroidal Neovascularization Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Sciences Inc Main Business
Table Gilead Sciences Inc Recent Development
Figure Global Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure Global Choroidal Neovascularization Revenue and Growth Rate (2017-2022)
Table Global Choroidal Neovascularization Sales by Regions (2017-2022)
Figure Global Choroidal Neovascularization Sales Market Share by Regions in 2021
Table Global Choroidal Neovascularization Revenue by Regions (2017-2022)
Figure Global Choroidal Neovascularization Revenue Market Share by Regions in 2021
Figure North America Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure Europe Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure China Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure Japan Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Figure Other Regions Choroidal Neovascularization Sales and Growth Rate (2017-2022)
Table Global Choroidal Neovascularization Sales by Big Type (2017-2022)
Table Global Choroidal Neovascularization Sales Market Share by Big Type (2017-2022)
Figure Global Choroidal Neovascularization Sales Market Share by Big Type in 2019
Table Global Choroidal Neovascularization Revenue by Big Type (2017-2022)
Table Global Choroidal Neovascularization Revenue Market Share by Big Type (2017-2022)
Table Global Choroidal Neovascularization Revenue Market Share by Big Type in 2019
Figure Global Intravenous Sales Growth Rate (2017-2022)
Figure Global Intravenous Price (2017-2022)
Figure Global Intravitreal Sales Growth Rate (2017-2022)
Table Global Choroidal Neovascularization Sales by Big Application (2017-2022)
Table Global Choroidal Neovascularization Sales Market Share by Big Application (2017-2022)
Figure Global Choroidal Neovascularization Sales Market Share by Big Application in 2019
Figure Global Extreme Myopia Sales Growth Rate (2017-2022)
Figure Global Malignant Myopic Degeneration Sales Growth Rate (2017-2022)
Figure Global Age-Related Developments Sales Growth Rate (2017-2022)
Figure Global Choroidal Neovascularization Sales and Growth Rate (2022-2027)
Figure Global Choroidal Neovascularization Revenue and Growth Rate (2022-2027)
Table Global Choroidal Neovascularization Sales Forecast by Regions (2022-2027)
Table Global Choroidal Neovascularization Market Share Forecast by Regions (2022-2027)
Figure North America Sales Choroidal Neovascularization Market Forecast (2022-2027)
Figure Europe Sales Choroidal Neovascularization Market Forecast (2022-2027)
Figure China Sales Choroidal Neovascularization Market Forecast (2022-2027)
Figure Japan Sales Choroidal Neovascularization Market Forecast (2022-2027)
Figure Southeast Asia Sales Choroidal Neovascularization Market Forecast (2022-2027)
Figure Other Regions Sales Choroidal Neovascularization Market Forecast (2022-2027)
Table Global Choroidal Neovascularization Sales Forecast by Type (2022-2027)
Table Global Choroidal Neovascularization Market Share Forecast by Type (2022-2027)
Table Global Choroidal Neovascularization Sales Forecast by Application (2022-2027)
Table Global Choroidal Neovascularization Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Choroidal Neovascularization
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Choroidal Neovascularization Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Choroidal Neovascularization Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Choroidal Neovascularization Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Choroidal Neovascularization Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Choroidal Neovascularization Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Choroidal Neovascularization Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Choroidal Neovascularization Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Choroidal Neovascularization Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)